Covishield

New Delhi: India is among the 33 counties from where fully vaccinated travellers will be allowed to enter the United States beginning November and Covishield is the only India-made vaccine that is in the list of approved vaccines as of now.…

Serum Institute of India (SII) is confident of getting approval for Covishield from European Medicines Agency (EMA) within a month. SII’s CEO Adar Poonawalla also said that the issue of vaccine passports should be on the basis of…

New Delhi: Drugs Controller General of India (DCGI) has given Cipla approval to import Moderna's COVID-19 vaccine for restricted emergency use in the country. Moderna’s COVID-19 vaccine will be the fourth vaccine to be administered…

New Delhi: The World Health Organization is yet to approve Covaxin, leaving in a fix those overseas-bound students and professionals who had taken India’s indigenously-developed vaccine. Now, even Serum Institute’s Covishield – Indian…

New Delhi: AstraZeneca joins other vaccines that are effective against the Delta variant. COVID-19 Vaccine AstraZeneca offers high levels of protection against the Delta variant (B.1.617.2; formerly the ‘Indian variant), new data…

Can the same person be administered two different COVID-19 vaccines to the same person? That, too, in the space of five minutes? However bizarre it might sound, that is exactly what happened in Bihar. A 63-year-old woman was given both…

New Delhi: The call to increase the interval between two doses of Covishield was on the basis of scientific evidence and taken in a transparent manner, according to NTAGI Chair NK Arora on Tuesday. Also, according to a tweet by the Union…

The three vaccines India is using currently – Covaxin, Covishield and Sputnik V – are all being administered in two doses to uninfected people. But is a single dose a better option? According to a recent study, a single dose of Covishield…

Mumbai/Hyderabad: COVID-19 vaccines — Covishield and Covaxin — could produce a high immune response in up to 95 per cent of recipients and prevent serious disease in those infected after inoculation, a ‘real-world’ study of the vaccinated…

New Delhi: Covishield-maker Serum Institute of India (SII) has sought indemnity from liability or legal protection from any claims linked any severe side effects from the company’s COVID-19 vaccine. Notably, foreign vaccine-makers Pfizer…